Altimetry Authority
Podcast featuring market updates from Rob Spivey and Joel Litman
info_outline
Nuclear Energy & Defense Stocks: Why Wall Street’s Wrong Again
07/25/2025
Nuclear Energy & Defense Stocks: Why Wall Street’s Wrong Again
Nuclear Energy & Defense Stocks: Why Wall Street’s Wrong Again - In this episode of The Altimetry Authority, we break down why nuclear energy and defense stocks are attracting serious attention from investors, and why mainstream Wall Street analysts are missing the mark… again. We explore the massive capital flowing into U.S. infrastructure, AI data centers, and military defense, and how this is quietly fueling gains in companies like Constellation Energy and major defense contractors. Plus, we dig into the geopolitical tension between the U.S., China, and Russia, and what it means for global markets and energy security. Then, we turn to Dollar General — is Wall Street underestimating this retailer during an inflation-driven “trade down” economy? Finally, we analyze Rheinmetall, Germany’s biggest defense stock. Has it peaked, or is there more room to run? Chapters: – Intro: AI, Energy, and War – Russia’s Weakness: The “Paper Bear” Explained – China’s Tax System and Black Market Economy – Betting on America: Why the U.S. Keeps Winning – The AI Boom's Hidden Winner: Constellation Energy – Why Wall Street Is Mispricing Constellation – The Dollar General Turnaround: Inflation & Tariff Myths – What the Market’s Missing on Dollar General – Defense Spending Surge: NATO and Europe’s Shift – RHEINMETALL Stock: Booming for the Wrong Reasons? – Final Thoughts: Retail Mania and Valuation Risks – Thanks for Watching + Subscribe 📈 Whether you're watching markets daily or building a long-term portfolio, this episode is packed with actionable insights for anyone interested in energy stocks, defense stocks, and contrarian investing. 👇 Subscribe to stay ahead of the herd.
/episode/index/show/e803749f-df4c-4658-bcb5-3ef06af797cd/id/37547535
info_outline
How Top Investors Build A Winning Investment Strategy
07/25/2025
How Top Investors Build A Winning Investment Strategy
How Top Investors Build A Winning Investment Strategy isn't just a catchy title - it's exactly what this episode delivers. In this in-depth conversation, Professor Joel Litman and Director of Research Rob Spivey sit down with legendary money manager Dave Daglio, former CIO at BNY Mellon, who oversaw over $500 billion in assets, to break down the core principles that separate average investors from market-beating ones. You’ll learn: Why the best investors rely on a personalized checklist to guide decisions How to overcome confirmation bias and identify blind spots in your portfolio What retail investors consistently get wrong—and how to fix it The powerful investment lessons from Warren Buffett, Charlie Munger, and Stanley Druckenmiller Why cash-on-cash returns, price discipline, and incentive alignment are critical to long-term gains The truth about Wall Street analysts and the media echo chamber Timestamps Intro Investor Checklists Institutional Biases The Street is Not Your Friend Average Investor's Shared Fictions The Best Way to Play AI Regime Change Worries Whether you manage your own portfolio or work with an advisor, this episode is packed with timeless investing insights to help you build a smarter, more consistent investment process. 👉 Get free daily email updates here:
/episode/index/show/e803749f-df4c-4658-bcb5-3ef06af797cd/id/37547440
info_outline
Exposed: $150,000 Tariff Tax Break, GDP's AI Secret, and a Slow-Motion Student-Loan Apocalypse
07/25/2025
Exposed: $150,000 Tariff Tax Break, GDP's AI Secret, and a Slow-Motion Student-Loan Apocalypse
In this episode of Altimetry Authority, we expose... The truth behind the negative GDP headlines – and why real GDP actually grew last quarter, thanks to AI What you should think about tariffs if you make under $150,000 a year (it could be a massive tax break) How the slow-motion student-loan apocalypse could blow up consumer spending The only news outlet getting the DOGE story even close to right... and why it's still missing the real story Why Wall Street is getting almost everything wrong about Twilio (TWLO) The real winner from 3G's Skechers (SKX) acquisition Timestamps - Introduction - The GDP Secret - $150,000 Tariff Winners - Student-Loan Apocalypse - DOGE Is Just Warming Up - Wall Street's Wrong on Twilio (TWLO) - 3G's Skechers (SKX) Buyout Sign up for free daily updates here:
/episode/index/show/e803749f-df4c-4658-bcb5-3ef06af797cd/id/37547320
info_outline
The Small Cap Stock Advantage No One’s Talking About
07/25/2025
The Small Cap Stock Advantage No One’s Talking About
We uncover why small cap stocks may be the most overlooked opportunity in the market right now. While headlines scream recession, inflation, and tariffs, savvy investors are quietly targeting high-dispersion, low-beta small caps that aren’t weighed down by institutional selling or mainstream coverage. We explain: Why small caps can outperform during market volatility How big institutions are too big to benefit from these hidden gems Real examples of small cap stocks that exploded during past downturns The two breakout themes for 2025: AI enablers and the supply chain supercycle How to think like Buffett when he said: “I could make you 50% a year—if I could invest small enough.” Timestamps Introduction Small Cap Stocks: Cure for Recession Panic End of U.S. Exceptionalism Wrong About Hyperscalers ServiceNow (NOW) FirstSolar and GIANT Tariffs If you’re a financial advisor, individual investor, or just someone who wants to get ahead of the next wave, don’t miss this. Sign up for free daily updates here:
/episode/index/show/e803749f-df4c-4658-bcb5-3ef06af797cd/id/37547180
info_outline
The Government Shift That Could Unleash a Defense & AI Investment Boom
07/25/2025
The Government Shift That Could Unleash a Defense & AI Investment Boom
This is the inside view of how U.S. government priorities could drive the next leg of growth in defense, tech, and infrastructure. In a special edition of The Altimetry Authority Show, Professor Joel Litman and Rob Spivey are joined by Colonel Jon Shaffner (Ret.) to break down how federal spending, modernization, and geopolitical risks are setting the stage for a major wave of defense and tech contracts. In this episode, we cover: Why the real story behind tariffs isn’t trade—it’s national security How AI and Doge (the government’s digital overhaul) could unlock massive efficiencies What record-breaking defense conference attendance tells us about future military spending How geopolitical tensions with China, Iran, and Russia are influencing procurement and gold buying The overlooked investment opportunity in small-cap defense and AI contractors Wall Street isn’t tracking Timestamps Introduction Tariffs and Delays Defense DOGE A D.C. Recession? The Real DOGE Story The Geopolitical Landscape Don’t forget to like, subscribe, and click the bell for unfiltered insights from the top minds in finance and strategy. 👉 Be sure to join the free Altimetry Daily Authority newsletter for ongoing updates:
/episode/index/show/e803749f-df4c-4658-bcb5-3ef06af797cd/id/37547125
info_outline
The 1 Big Lie About Gold’s Rally — And What Wall Street’s Missing on Pharma, CrowdStrike & Illumina
07/25/2025
The 1 Big Lie About Gold’s Rally — And What Wall Street’s Missing on Pharma, CrowdStrike & Illumina
This week Joel and Rob cover gold’s rally, RFK Jr’s war on pharma, CrowdStrike’s baffling upgrade, and why Illumina might be a stealth rebound story. Timestamps Introduction Profits vs. Tariffs Gold Rush Pharma Shakeup Going Against the Crowdstrike Illumination The headlines say one thing—but when you look deeper at the data and embedded expectations, the market’s telling a very different story. GOLD & DE-DOLLARIZATION Everyone says gold’s 50% rally is about the collapse of the U.S. dollar—but the real reason is the collapse of other currencies and geopolitical risk, not the dollar disappearing. MAKE AMERICA HEALTHY AGAIN: RFK Jr vs Pharma RFK Jr. may not ban pharma ads, but his critique of pharma’s outsized profit share is real: over 50% of U.S. healthcare profits go to pharma. Treating drugs like consumer goods is what’s broken—and fixing that could save $100 billion in government spending. WALL STREET’S WRONG AGAIN: CROWDSTRIKE BTIG’s recent CrowdStrike upgrade makes no sense when you look under the hood. Valuation is stretched, sentiment is weak, and this call looks like it’s about banking flow, not fundamentals. EARNINGS UNCENSORED: ILLUMINA Activist investor Corvex Management just grabbed a board seat at Illumina. With the GRAIL disaster priced in and China issues behind them, this could be a buy-the-dip moment—and a compelling turnaround play in the biotech space. Sign up for free daily updates:
/episode/index/show/e803749f-df4c-4658-bcb5-3ef06af797cd/id/37547050
info_outline
DC-Driven Market Meltdown | Fed Shakeup, $81T Citi Error & Eli Lilly’s Big Bet
07/25/2025
DC-Driven Market Meltdown | Fed Shakeup, $81T Citi Error & Eli Lilly’s Big Bet
The market is melting down—thanks to Washington. What should investors do next? This week, we’re breaking down DC’s impact on the markets, a major shift at the Fed, and why America runs on credit. Topics covered in this episode: ✅ DC-Driven Market Meltdown – What’s happening, and how should you react? ✅ Fed Shakeup & Bank Consolidation – Michelle Bowman’s move to Vice Chair & what it means for the economy ✅ Eli Lilly’s $27B Expansion – A smart investment or a costly mistake? ✅ Citigroup’s $81 Trillion Error – How did Citi make this mistake, and what does it mean for investors? ✅ Qualcomm & Wall Street’s Blind Spot – Analysts focus on Apple & China, but what’s the real catalyst? View by Section (Timestamps) Start DC-Driven Market Meltdown Fed Shakeup & Bank Consolidation Eli Lilly’s $27B Expansion Citigroup’s $81 Trillion Error Qualcomm & Wall Street’s Blind Spot Sign up for Joel and Rob's daily e-letter at 🚀 Stay ahead of the markets with the latest insights & expert analysis! 👍 Like, comment, and subscribe for more updates.
/episode/index/show/e803749f-df4c-4658-bcb5-3ef06af797cd/id/37546060
info_outline
DOGE Email Grab, China’s Massive Debt & Apple’s $500B Bet
07/22/2025
DOGE Email Grab, China’s Massive Debt & Apple’s $500B Bet
In today's episode Joel Litman and Rob Spivey break down the latest news, including the DOGE email grab, China’s debt crisis, and why Wall Street got it wrong (again) with Snowflake (NYSE: SNOW). Additionally they also analyze Apple’s massive $500B investment and what it could mean for investors down the line. Topics covered in this episode: DOGE’s email push – What are they really after? Market fragility – Why recession talks & tariffs are shaking risk assets China’s economic reality – Should we really be bullish on Alibaba? Snowflake (NYSE: SNOW) stock miss – How Wall Street keeps mispricing it Apple’s $500B investment – What it means for investors Cereal industry shake-up – Why the USDA food pyramid should be flipped upside down - DOGE - Fragile Markets - China Pop - Snowflake - Apple - Breakfast of Champions Stay ahead of market trends with expert insights from Joel Litman and Rob Spivey—sign up for their free daily e-letter, Daily Authority, at and get the real story behind the headlines every morning! Like, comment, and subscribe for more updates.
/episode/index/show/e803749f-df4c-4658-bcb5-3ef06af797cd/id/37507575
info_outline
Trump’s Tariffs, Pharma Price Shakeup & Inflation Chaos
07/22/2025
Trump’s Tariffs, Pharma Price Shakeup & Inflation Chaos
Trump’s tariffs and taxes—what’s really happening beyond the headlines. While the media focuses on Elon Musk’s latest moves, hosts Rob Spivey and Joel Litman uncover the pharma industry’s hidden costs and how Americans pay way more for the same medication. Plus, what Amazon’s earnings tell us about the market and why Citi is still cutting its price target. In today's episode: Trump’s tariffs & tax policies – The real impact on markets Elon Musk: Chaos or strategy? – What’s actually happening Pharma price wars – Why Americans overpay & which companies are at risk Amazon vs. Citi – Earnings surprise vs. price cuts Alphabet’s massive year – What’s next for big tech Global inflation crisis – Where currency debasement is really happening 📊 Don’t miss our full breakdown of stock market trends and investment insights! Like, comment, and subscribe to be notified for more content. Stay ahead of the market with expert insights from Joel Litman and Rob Spivey—sign up for their free daily e-letter, Daily Authority, at ! Introduction Tariffs Elon and the D.O.D. Big Pharma Wall Street Wrong Again Earnings Uncensored Airlines Outro
/episode/index/show/e803749f-df4c-4658-bcb5-3ef06af797cd/id/37507425